HCV genotyping using statistical classification approach.

Area of Science:

• Virology
• Bioinformatics
• Genetics

Background:

• Hepatitis C Virus (HCV) genotype influences disease severity and treatment response.
• Accurate and rapid HCV genotype determination is essential for effective clinical management of chronic infections.

Purpose of the Study:

• To develop a method for fast and accurate determination of Hepatitis C Virus (HCV) genotypes.
• To identify reliable nucleotide sequence signatures for predicting HCV genotypes and subtypes.

Main Methods:

• Constructed a global Position Weight Matrix (PWM) for the HCV genome using public nucleotide sequences.
• Selected genotype-specific nucleotide sequence signatures from 5' NCR, CORE, E1, and NS5B regions.
• Employed Support Vector Machine (SVM) and random forest classification with 10-fold cross-validation.

Main Results:

• Nucleotide signatures from NS5B and E1 regions showed superior discriminant power for differentiating HCV genotypes and subtypes compared to 5' NCR and CORE.
• Achieved over 99% prediction accuracy for HCV genotypes using SVM and random forest models on datasets of 1134 (NS5B) and 947 (E1) sequences.
• Detailed prediction accuracy for individual genotypes was reported.

Conclusions:

• Nucleotide sequence signatures, particularly from NS5B and E1 regions, are effective for accurate HCV genotype prediction.
• Computational methods like SVM and random forest offer highly accurate classification of HCV genotypes.
• This approach can significantly aid in the clinical management of patients with chronic HCV infections.